<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body> <br />                            WRN helicase promotes repair DNA double-strand breaks <br />                            caused aberrant mismatch repair chromium-DNA adducts <br />   <br />                            Abstract <br />                                  Recent studies yeast processing DNA-double strand breaks (DSB)                                  recombination repair involves Sgs1 helicase. Human cells Sgs1 homologues                                  unknown selectivity significance repair different DSB types. examined NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                  importance WRN helicase repair G2-specific DSB caused abnormal mismatch repair <br />                                  (MMR) ternary Cr-DNA adducts. Cr(VI) induced rapid dispersal WRN                                  nucleolus resulting prolonged retention nucleoplasm. loss MSH2 MLH1 <br />                                  MMR proteins abolished long-term initial WRN relocalization. WRN-deficient <br />                                  fibroblasts hypersensitive Cr(VI)-induced clonogenic death contained high levels                                  persistent DSB detected &#206;&#179;-H2AX/53BP1 foci pulsed-field gel electrophoresis. WRN                                  involved recombination repair Cr-induced DNA damage, evidenced WRN-RAD51 <br />                                  colocalization defective formation RAD51 foci absence WRN. accumulation <br />                                  unrepaired DSB WRN-depleted cells rescued inactivation MMR, indicating <br />                                  MMR-generated DSB key substrate WRN action Cr(VI)-treated cells. <br />                                  Competition limited amounts WRN primary cells G2 processes telomere <br />                                  rebuilding recombinational repair expected increase persistence Cr-induced DSB                                  cause telomeric abnormalities tissues chronically chromate-exposed workers. work <br />                                  provides demonstration major importance WRN repair specific class                                  DSB human cells. <br />  <br />  <br />                            Introduction <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Werner syndrome (WS) rare genetic disorder premature ageing manifested                                             early appearance gray hair, cataracts, scleroderma, diabetes increased incidence                                             cancer.1&#226;&#8364;&#8220;3 WRN, protein mutated Werner syndrome, unique  <br />                                             member human RecQ helicase family contains helicase exonuclease <br />                                             activities.1,3 Normal localization WRN nucleolar4&#226;&#8364;&#8220;6 afflicted individuals,                                             protein missing nuclear localization signal resulting exclusion                                             nucleus.1,2 WS cells display prolonged S-phase,7 low proliferative capacity3 increased <br />                                             sensitivity drugs S-phase dependent toxicity.8&#226;&#8364;&#8220;10 preferred substrates WRN <br />                                             action include various types 3- 4-way DNA junctions, bubbles, extrahelical loops                                             DNA overhangs.3,11,12 abnormal DNA structures arise spontaneously areas <br />                                             DNA repeats induced incomplete repair replication. WRN                                             capable resolving broad range alternative DNA structures ability                                             recognize structures process unwinding cleavage reactions.1&#226;&#8364;&#8220;3 <br />  <br />  <br />                                             WRN interacts proteins involved repair DNA double-strand breaks <br />                                             (DSB)13&#226;&#8364;&#8220;18 localizes sites laser-induced DSB live cells.19  WS <br />                                             cells exhibited mild sensitivity ionizing radiation clonogenic survival <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             experiments,2,16 indicative minor role WRN overall DSB <br />                                             repair. Recent studies yeast RecQ helicase Sgs1 stimulated <br />                                             recombination repair DSB essential function redundant DNA <br />                                             ends resection pathways.20,21 RecQ helicase BLM appears play role analogous                                             Sgs1 campthothecin-treated human cells acts parallel EXO1                                             promote recombination-associated foci cell survival.22 presence RecQ <br />                                             members human cells potentially indicates individual helicases participate                                             repair different classes DSB. currently unknown repair specific DSB                                             human cells particularly dependent WRN involves helicase. <br />  <br />                                             work, investigated importance WRN cellular survival repair DSB <br />                                             induced potent human carcinogen chromium(VI). main source DSB Cr(VI)- <br />                                             treated human cells misprocessing Cr-DNA damage mismatch repair (MMR).23&#226;&#8364;&#8220;25 <br />                                             majority Cr-induced DSB formed G2 phase following replication Cr- <br />                                             adducted DNA.23,24 Ternary Cr-DNA adducts, cysteine-Cr-DNA ascorbate-Cr- <br />                                             DNA crosslinks, particularly good substrates recognition MMR proteins.24,25 <br />                                             adducts primary cause mutagenic responses generated shuttle- <br />                                             vector plasmids damaged Cr(VI) reduction vitro ascorbate26,27 cysteine.28 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Chronic formation toxic DSB MMR activity repetitive exposures Cr(VI)                                             proposed promote selection transformation-prone, Cr-resistant cells lacking <br />                                             MMR, providing explanation unusually high frequency microsatellite <br />                                             instability (marker inactive MMR) lung cancers chromate workers.29 Unlike <br />                                             agents MMR-dependent mechanisms cytotoxicity,30&#226;&#8364;&#8220;32 formation DSB <br />                                             Cr-exposed cells unusually rapid results unprecedented activation                                             MSH6 MSH3 branches MMR.25 MSH3 specifically recognizes repairs <br />                                             mismatches containing insertion/deletion loops,33,34 pointing potential formation                                             structures Cr-damaged DNA. Extrahelical loops high affinity substrates                                             WRN helicase1&#226;&#8364;&#8220;3 interfere activity DNA helicases.  <br />                                             possible repair MMR-generated DSB Cr-damaged DNA engage WRN. <br />                                             Cr-induced DSB suited testing involvement WRN homologous <br />                                             recombination principal DSB repair process S/G2 cells main target <br />                                             activity RecQ helicases lower organisms.20,21 <br />  <br />                               Materials Methods <br />                               Cell cultures drug treatments <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Human SV40 transformed fibroblast lines GM00637H (NF cells) GM00847 (LNS cells) <br />                                             purchased Coriell Cell Repository. SV40 immortalized Werner syndrome <br />                                             fibroblasts AG11395 (WS cells) obtained NIA Aging Cell Culture Repository. <br />                                             Primary human lung IMR90 fibroblasts colon HCT116 (MLH1&#226;&#710;&#8217;/&#226;&#710;&#8217;) cells purchased <br />                                             American Type Culture Collection. HCT116+ch3 (MLH1+) cell line gift <br />                                             T. Kunkel. NF, WS IMR90 fibroblasts cultured DMEM supplemented <br />                                             penicillin-streptomycin serum (15% NF WS, 10% IMR90). LNS cells <br />                                             grown MEM 10% serum. HCT116 cells grown DMEM-F12 medium <br />                                             containing 10% serum penicillin-streptomycin. Media HCT116+ch3 cells <br />                                             additionally included 600 &#206;&#188;g/ml geneticin. cell lines grown 37&#194;&#176;C humidified <br />                                             atmosphere containing 95% air-5% <span id='am-6' about='obo:IMR_0200324' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-7' property="oboInOwl:hasDbXref" content="KEGG:C00011" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-9' property="oboInOwl:id" content="IMR:0200324" datatype="xsd:string"></span><span id='am-10' property="rdfs:label" content="CO2" datatype="xsd:string"></span>CO2</span>. Cells exposed K2CrO4 [Cr(VI)] 3 hr                                             serum-free medium. increase cellular ascorbate concentrations, cells incubated                                             90 min 1 mM dehydroascorbic acid Krebs-HEPES buffer supplemented 0.5 <br />                                             mM glucose.35 Cellular ascorbate measured modified HPLC procedure based  <br />                                                 Cell Cycle. Author manuscript; available PMC 2011 November 30. <br />                             Zecevic et al.                                                                                          Page 3 <br />  <br />  <br />                                             fluorescent detection specific conjugate 1,2-diamino-4,5-dimethoxybenzene <br />                                             dihydrochloride.36 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Clonogenic survival <br />                                             total 2000 cells seeded 100-mm dishes day prior treatments                                             Cr(VI). dishes used dose. 14 days exposure, colonies                                             fixed 100% methanol stained Giemsa solution counted. Clonogenic <br />                                             experiments repeated twice. <br />  <br />                               Western blotting <br />                                             Cells collected scraping, washed twice cold phosphate-buffered saline (PBS) <br />                                             resuspended buffer containing 50 mM Tris pH 8.0, 250 mM NaCl, 1% NP40, 0.1% <br />                                             SDS, 5 mM EDTA, 2 mM Na3VO4, 10 mM Na2P2O7, 10 mM NaF, 1 mM PMSF                                             protease inhibitor cocktail. Lysates incubated ice 10 min cell debris <br />                                             spun speed 10,000 &#195;&#8212; g 5 min 4&#194;&#176;C. Samples denatured 2X <br />                                             loading buffer 10% 2-mercaptoethanol boiled 10 min. Proteins separated <br />                                             SDS-polyacrylamide gel electrophoresis electrotransferred ImmunoBlot PVDF <br />                                             membrane (Bio-Rad). Primary antibodies rabbit polyclonal anti-WRN (Santa Cruz <br />                                             Biotechnology), mouse anti-MLH1, anti-MSH6 anti-MSH2 (BD Biosciences). Protein <br />                                             bands visualized using horseradish peroxidase-conjugated secondary antibodies <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             (Upstate) enhanced chemiluminescence kit (Amersham). <br />  <br />                               Stable shRNA knockdowns <br />                                             Stable depletion protein levels achieved expression short hairpin RNA <br />                                             (shRNA) pSUPER-RETRO retroviral vector (Oligoengine). sequence WRN- <br />                                             targeting shRNA 5&#226;&#8364;&#178;-GTGTATAGTTACGATGCTA-3&#226;&#8364;&#178; MSH6 5&#226;&#8364;&#178;- <br />                                             GGTGATCCCTCTGAGAACT-3&#226;&#8364;&#178;. control GFP-targeting sequence 5&#226;&#8364;&#178;- <br />                                             GCAAGCTGACCCTGAAGTT-3&#226;&#8364;&#178;. luciferase-targeting sequence 5&#226;&#8364;&#178;- <br />                                             GCGACCAACGCCTTGATTG-3&#226;&#8364;&#178;. Double-stranded oligonucleotides ligated                                             pSUPER-RETRO vector linearized BamHI HindIII. pSUPER- <br />                                             RETRO vectors depletion MLH1 MSH224 details retroviral infections37 <br />                                             described previously. double knockdown experiments, NF cells                                             infected pSUPER-puro vectors, selected puromycin week  <br />                                             infected pSUPER-neo vectors selected 400 &#206;&#188;g/ml geneticin weeks.                                             avoid loss shRNA efficacy long-term cultures, new stocks infected cells used <br />                                             4 weeks. <br />  <br />                               Immunofluorescence <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Cells grown Superfrost Plus slides exposed Cr(VI) 3 hr, returned                                             complete medium. selected times, cells washed twice PBS fixed                                             2% paraformaldehyde PBS 20 min room temperature. Cells                                             permeabilized 20 min 1% Triton X-100, followed incubation 3% fetal <br />                                             bovine serum PBS 1 hr. Primary antibodies WRN (rabbit polyclonal <br />                                             antibodies, Santa Cruz) B23 (mouse monoclonal antibody Chemicon) used                                             1:200 dilution incubated overnight 4&#194;&#176;C. primary cells Rad51 staining (anti- <br />                                             Rad51 mouse monoclonal antibody Abcam, 1:400 dilution), cells incubated                                             37&#194;&#176;C 3 hr overnight incubation 4&#194;&#176;C. DSB repair sites labeled                                             simultaneous incubation primary antibodies &#206;&#179;-H2AX 1:1000 dilution (Upstate)                                             anti-53BP1 1:500 dilution (Santa Cruz) 2 hr 37&#194;&#176;C humidified chamber.                                             secondary antibodies, Alexa Fluor 488-conjugated anti-mouse immunoglobulin G, Alexa <br />                                             Fluor 594-conjugated anti-mouse immunoglobulin G, Alexa Fluor 488-conjugated anti- <br />  <br />  <br />                                                 Cell Cycle. Author manuscript; available PMC 2011 November 30. <br />                             Zecevic et al.                                                                                           Page 4 <br />  <br />  <br />                                             human immunoglobulin G Alexa Fluor 594-conjugated anti-rabbit immunoglobulin G <br />                                             (Molecular Probes) incubated 1 hr room temperature. Antibodies diluted                                             PBS containing 1% bovine serum albumin 0.5% Tween 20, detection &#206;&#179;- <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             H2AX antibodies diluted 2% albumin-PBS solution. Slides                                             mounted Vectashield hard set mounting medium DAPI (Vector Laboratories). <br />                                             Fluorescence images recorded Zeiss Axiovert 100 confocal microscope                                             analyzed Phoenix software. Experiments repeated 3&#226;&#8364;&#8220;6 slides 100 <br />                                             cells analyzed slide. <br />  <br />                               Pulsed-field gel electrophoresis (PFGE) <br />                                             Cells exposed Cr(VI) 3 hr returned complete medium 6 hr 24 hr. <br />                                             PFGE plugs prepared using BioRad Mammalian CHEF Genomic Plug Kit 106 cells/ <br />                                             plug incubated proteinase K buffer [100 mM EDTA, 1% N-laurylsarcosyl, 10 mM <br />                                             Tris, pH 8.0, proteinase K 1 mg/ml] 20&#194;&#176;C 24 hr. plugs washed 5 times                                             wash buffer [20 mM Tris, pH 8.0 50 mM EDTA] agitation prior loading. <br />                                             PFGE performed using 1% gel (Pulsefield Certified Megabase Agarose, BioRad)                                             0.5X TBE buffer CHEF Mapper XA Pulsed Field Electrophoresis (BioRad)                                             18 hr 14&#194;&#176;C following current conditions: 120&#194;&#176; field angle, 240 s switch time, 4 <br />                                             V/cm. DNA visualized staining ethidium bromide. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Results <br />                               Increased sensitivity WRN-deficient cells Cr(VI) toxicity <br />                                             Expression telomerase known compensate absence WRN human WS <br />                                             cells.38,39 presence active telomerase responsible suppression premature <br />                                             aging phenotype Wrn-knockout mice.40,41 Introduction active hTERT BJ human <br />                                             fibroblasts increased resistance strongly inhibited induction chromosomal <br />                                             instability Cr(VI),42 indicating telomerase-immortalized cells altered <br />                                             processing Cr-induced damage.  chose perform investigation                                             telomerase-negative human cells. potential role WRN helicase cellular responses                                             Cr-DNA damage examined clonogenic survival Cr-treated WRN-expressing <br />                                             NF WRN-null WS fibroblasts (Fig. 1A). WS cells displayed high sensitivity                                             clonogenic lethality Cr(VI) colonies surviving 10 &#206;&#188;M Cr                                             approximately 50% NF cells clonogenically viable dose. NF WS cells <br />                                             isogenic, created stable knockdown WRN protein NF cells expressing                                             targeting shRNA chromosomally integrated pSUPER-RETRO vector (Fig. 1B,                                             panel). selected shRNA decreased WRN levels 10-fold compared NF cells <br />                                             expressing nonspecific shRNA (GFP). Using isogenic model WRN deficiency, NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             absence WRN caused hypersensitivity Cr(VI) lethality (Fig. 1C). <br />                                             confirm findings, constructed stable WRN knockdown telomerase- <br />                                             negative LNS fibroblasts (Fig. 1B, panel). LNS cells resistant <br />                                             Cr(VI) relative NF cells, WRN knockdown cells resulted essentially                                             degree sensitization Cr(VI) toxicity (Fig. 1D). <br />  <br />                               Altered intranuclear localization WRN Cr(VI) damage <br />                                             WRN typically nucleolus primary transformed human cells.5 <br />                                             Costaining WRN nucleolar marker B23 showed majority NF cells                                             exhibited nucleolar localization WRN (Fig. 2A). response Cr(VI) exposure, WRN <br />                                             relocalized nucleolus nucleoplasm. nucleoplasmic localization                                             observed immediately 3 hr-long exposures 10&#226;&#8364;&#8220;20 &#206;&#188;M Cr(VI) retained                                             treated cells 24 hr post-treatment. majority relocalized WRN produced largely <br />                                             uniform diffuse staining pattern. Costaining Cr(VI)-treated cells antibodies WRN <br />  <br />  <br />                                                 Cell Cycle. Author manuscript; available PMC 2011 November 30. <br />                             Zecevic et al.                                                                                          Page 5 <br />  <br />  <br />                                             marker DSB, &#206;&#179;&#226;&#8364;&#8220;H2AX,43 showed DSB-positive cells displayed                                             diffuse WRN nuclear distribution &#206;&#179;&#226;&#8364;&#8220;H2AX foci colocalized WRN (Fig. <br />                                             2B,C). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Persistence DSB absence WRN <br />                                             observed colocalization WRN &#206;&#179;&#226;&#8364;&#8220;H2AX foci suggested WRN                                             involved repair Cr(VI)-induced DSB. test possibility, examined effects <br />                                             WRN deficiency persistence DSB Cr(VI) removal. presence DSB <br />                                             detected appearance 53BP1 &#206;&#179;&#226;&#8364;&#8220;H2AX foci cells exhibiting focal <br />                                             staining proteins scored DSB-positive (Fig. 3A). 53BP1 recruited <br />                                             following remodeling chromatin regions flanking break44 serves second <br />                                             marker DSB. Levels DSB induced moderate doses Cr(VI) typically approached <br />                                             peak 6 hr post-exposure.23,24 Treatment NF LNS cells moderately <br />                                             toxic Cr(VI) doses (~60% clonogenic survival) resulted strong production DSB <br />                                             foci 6 hr post-Cr WRN depletion significant effect initial induction                                             DSB (Fig. 3B,C).  24 hr post-exposure, approximately twice                                             DSB foci-positive cells WRN knockdown compared shGFP controls. Cr(VI) <br />                                             requires reductive activation inside cells order cause DNA damage.45 Human cells                                             culture contain low levels ascorbate,25,35 rapid cellular reducer                                             Cr(VI).46,47 Restoration physiological levels ascorbate primary human cells strongly <br />                                             potentiated formation DSB Cr(VI).24 HPLC analyses detected approximately <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             25 &#206;&#188;M ascorbate NF cells, lower physiological levels <span id='am-1' about='obo:IMR_0001656' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-2' property="rdfs:label" content="vitamin" datatype="xsd:string"></span><span id='am-3' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:id" content="IMR:0001656" datatype="xsd:string"></span><span id='am-5' property="oboInOwl:hasDbXref" content="CHEBI:27305" datatype="xsd:string"></span>vitamin</span> <br />                                             tissues.47  preloaded NF cells ascorbate 0.25 mM                                             examined DSB accumulation 24 hr post-Cr (Fig. 3D,E). primary cells,24 increasing <br />                                             cellular ascorbate levels enhanced DSB-producing activity Cr(VI), WRN depletion <br />                                             resulted presence persistent DSB exposure low 2 &#206;&#188;M Cr(VI), <br />                                             current EPA standard chromium drinking water.47 Analysis                                             chromosomal DNA PFGE confirmed importance WRN repair Cr- <br />                                             induced DSB evidenced 2.7-times (p&lt;0.01) higher levels remaining DNA breaks                                             WRN-depleted LNS cells 24 hr Cr(VI) exposure (Fig. 3F). Control LNS cells                                             normal WRN levels capable repairing majority DSB generated                                             50 &#206;&#188;M Cr(VI) WRN-depleted cells unable significant repair                                             fewer DSB induced 30 &#206;&#188;M Cr(VI) (Fig. 3G). <br />  <br />                               Attenuated formation RAD51 foci WRN-deficient cells <br />                                             majority Cr-induced DSB present G2 cells.23,24 DSB repair G2 cells <br />                                             occurs primarily homologous recombination,48,49 examined effect WRN                                             repair process. activity recombination repair assessed scoring foci NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             RAD51, essential recombination repair proteinsand specific marker                                             recombination repair sites.50 Treatment NF cells moderate 10 &#206;&#188;M highly <br />                                             toxic 20 &#206;&#188;M doses Cr(VI) did increase production RAD51 foci                                             background levels 6 hr post-exposure (Fig. 4A,B). 24 hr post-Cr, NF cells                                             nonspecific GFP-shRNA displayed significant induction RAD51 foci Cr(VI) <br />                                             doses WRN-depleted cells showed change relative untreated controls.  <br />                                             activation recombination repair NF cells significantly lagged induction DSB                                             presence WRN (Fig. 3B,C) absent cells WRN knockdown.                                             confirm findings, investigated formation RAD51 foci LNS cells (Fig. 4C). <br />                                             Control LNS cells showed strong induction RAD51 foci 6 hr post-Cr                                             WRN depletion completely abrogated recombination foci time. 24 hr post-Cr, <br />                                             WRN-depleted LNS cells displayed significant increase number RAD51 foci, <br />                                             modestly lower control cells.  cell lines showed strong <br />                                             positive effect WRN formation RAD51 foci. rapid activation  <br />  <br />                                                 Cell Cycle. Author manuscript; available PMC 2011 November 30. <br />                             Zecevic et al.                                                                                           Page 6 <br />  <br />  <br />                                             recombination repair LNS cells partially responsible higher <br />                                             resistance Cr(VI) lethality (Fig. 1D). analyzed RAD51 foci WRN-null WS <br />                                             cells treated 10 20 &#206;&#188;M Cr(VI), doses clearly genotoxic cells (Fig. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             1A). Cr(VI) dose caused marginal increase induction RAD51 foci                                             24 hr post-exposure (Fig. 4D), confirming importance WRN protein                                             initiation recombination repair Cr-DNA damage. large fraction Cr-induced <br />                                             RAD51 focus-positive NF LNS cells showed partial colocalization (ranging                                             20 80%) RAD51 foci WRN (Fig. 4E,F). <br />  <br />                               Mismatch repair (MMR)-mediated DNA lesions WRN <br />                                             main cause DSB human cells treated low moderately toxic doses Cr(VI) <br />                                             abnormal processing Cr-DNA crosslinks MMR.23&#226;&#8364;&#8220;25 observed                                             ascorbate, enhances DSB production aberrant MMR activity,24 increased                                             levels DNA breaks WRN-depleted cells Cr(VI) concentrations                                             nongenotoxic (Fig. 3D,E).  tested WRN responding secondary <br />                                             DNA lesions generated MMR. examined dynamics WRN localization                                             Cr(VI)-treated human HCT116 cells lacking expressing MLH1,                                             essential MMR proteins.33,34 majority control cells lines showed costaining <br />                                             WRN nucleolar marker B23, demonstrating MLH1 effect                                             retention WRN nucleoli unstressed cells (Fig. 5A). Immediately Cr(VI) <br />                                             exposure, WRN dispersed nucleolus nucleoplasm majority cells <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             irrespective MLH1 status. Similarly NF cells (Fig. 2), MLH1+ HCT116 cells                                             retained nucleoplasmic WRN 24 hr post-Cr. contrast, MLH1&#226;&#710;&#8217;/&#226;&#710;&#8217; HCT116 cells restored <br />                                             normal nucleolar localization WRN 3&#226;&#8364;&#8220;6 hr post-exposure. investigate                                             MMR-dependence WRN dynamics, created stable knockdowns MLH1 MSH2 <br />                                             MMR proteins primary human IMR90 fibroblasts (Fig. 5B). WRN <br />                                             relocalized IMR90 constructs immediately Cr(VI) exposure control <br />                                             Luc-shRNA cells retained WRN nucleoplasm, cells MLH1 MSH2 <br />                                             knockdowns restored nucleolar WRN staining 3 hr post-Cr (Fig. 5C).                                              initial relocalization WRN occurred directly response Cr(VI)-induced stress                                             long-term retention nucleoplasm required presence MMR proteins.                                             nucleoplasmic retention WRN binding MMR proteins,  <br />                                             immunoprecipitation experiments detectable association WRN MSH6                                             MSH2 control Cr(VI)-treated NF cells (Fig. 5D). MSH6 immunoprecipitates contained <br />                                             large amounts binding partner MSH2,33,34 validating effectiveness                                             employed procedure. Sensitization WRN-depleted cells Cr(VI) toxicity did appear <br />                                             result alterations MMR expression major MMR <br />                                             proteins MSH6, MSH2 MLH1 did vary GFP-shRNA WRN-shRNA <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             cells (Fig. 5E). Cr(VI) exposure significant effect protein levels WRN <br />                                             itself (Fig. 5E). <br />  <br />                                             observed MMR-dependent dynamics WRN absence direct interactions                                             MMR proteins suggested WRN responding MMR-induced DSB. test                                             possibility, constructed NF cells double knockdowns MSH6 WRN (Fig. 6A). <br />                                             depending Cr(VI) dose, knockdown MSH6 WRN-depleted cells <br />                                             completely abrogated significantly suppressed levels persistent DSB foci <br />                                             (Fig. 6B). presence ascorbate strongly potentiated formation DSB Cr(VI) <br />                                             (Fig. 3E) low doses essentially ascorbate-promoted DSB MMR-generated.24 <br />                                             depletion MSH6 completely eliminated presence persistent DSB                                             Cr-treated/ascorbate-preloaded cells WRN knockdown (Fig. 6C). effect quite <br />                                             striking, cells normal WRN levels (GFP/GFP controls) unable fully <br />                                             repair DSB. DSB induction, formation RAD51 foci Cr(VI) enhanced <br />  <br />  <br />                                                 Cell Cycle. Author manuscript; available PMC 2011 November 30. <br />                             Zecevic et al.                                                                                          Page 7 <br />  <br />  <br />                                             preloading control cells ascorbate MSH6 depletion abrogated appearance <br />                                             recombination-active cells (Fig. 6D,E). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Discussion <br />                                             work, WRN actively engaged cellular responses Cr(VI). <br />                                             Immediately short treatments carcinogen, WRN relocalized                                             nucleolus nucleoplasm remained 24 hr post-exposure. loss                                             WRN resulted increased clonogenic toxicity Cr(VI), demonstrating importance                                             RecQ-type helicase cell survival. Cellular reduction Cr(VI) generates transient <br />                                             oxidative stress formation redox-active CrV/IV intermediates51,52 yields <br />                                             stable Cr-DNA adducts.45 prolonged nucleoplasmic retention WRN Cr-treated <br />                                             cells, initial relocalization, dependent presence intact MMR.  <br />                                             early WRN movement likely caused cellular stress Cr(VI) metabolism <br />                                             subsequent nucleoplasmic presence reflected events involving MMR. <br />                                             Processing Cr-DNA adducts human MMR generates DSB secondary, toxic <br />                                             DNA lesions.23&#226;&#8364;&#8220;25 WRN played major role repair MMR-induced DSB <br />                                             Cr(VI)-treated human fibroblasts significant effects initial production                                             DNA breaks. presence unrepaired DSB likely responsible decreased <br />                                             survival WRN-depleted cells clonogenic assay. Poor repair DSB WRN- <br />                                             lacking cells associated deficiency activation early steps homologous <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             recombination, revealed absence severely delayed formation RAD51 foci <br />                                             Cr-DNA damage. Functional recombination repair known play important role <br />                                             cellular resistance Cr(VI) toxicity.53,54 <br />  <br />                                             Induction DSB MMR typically begins 1&#226;&#8364;&#8220;3 hr post-Cr exposure occurs                                             G2 cells following replication Cr-adducted DNA.23,24 late steps MMR- <br />                                             dependent processing Cr-DNA damage prior DNA breakage dependent                                             activity MSH3-MSH2 heterodimer (MutS&#206;&#178; complex).25 MutS&#206;&#178; dimer exhibits high <br />                                             specificity DNA loops various sizes,33,34 suggesting MMR-induced DSB                                             associated presence loops hairpins. presence loops hairpins <br />                                             interfere activity DNA-processing enzymes, DNA ends adjacent <br />                                             loops high affinity substrates WRN.2 Additionally, strong requirement WRN                                             initiation RAD51-dependent recombination Cr-treated cells                                             reflected limited availability EXO1 operates parallel pathway leading                                             activation recombination repair DSB.20&#226;&#8364;&#8220;22 role RecQ helicases DSB <br />                                             processing evident cells deficient EXO1/Exo1. EXO1 <br />                                             essential component human MMR,33,34 massive formation ternary Cr-DNA <br />                                             adducts recruiting MMR complexes stimulating activity expected sequester NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             major fraction low abundance exonuclease.22 <br />  <br />                                             MSH2-MSH3 MSH2-MSH6 mismatch-sensing complexes capable                                             stimulating DNA duplex unwinding WRN vitro.55 biological relevance                                             findings supported physical interactions WRN MSH2 yeast <br />                                             hybrid studies. High duplex unwinding activity promote DSB repair, helicase <br />                                             activity essential 5&#226;&#8364;&#178;&#226;&#8224;&#8217;3&#226;&#8364;&#178; exonuclease degradation DSB ends RecQ/Sgs1- <br />                                             dependent recombination process.20&#226;&#8364;&#8220;22 MMR proteins present sites Cr- <br />                                             induced DSB,25 recruit WRN stimulate strand unwinding activity                                             contribute prominent role DSB ends processing necessary RAR51 <br />                                             loading.  far unable detect interactions WRN MSH2                                             MSH6 IP control Cr(VI)-treated cells. possible association                                             WRN MMR proteins predominantly occurs chromatin-bound DSB repair complexes <br />                                             remained insoluble protein extraction procedures IP procedure <br />  <br />  <br />                                                 Cell Cycle. Author manuscript; available PMC 2011 November 30. <br />                             Zecevic et al.                                                                                                           Page 8 <br />  <br />  <br />                                              employed stringent lysis/washing conditions. Alternatively, WRN recruited                                              sites Cr-induced DSB components MMR, upstream-acting MLH1- <br />                                              PMS2 heterodimer.55 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Implications Cr(VI) genotoxicity <br />                                              Long DSB persistence defective formation RAD51 recombination foci absence <br />                                              WRN indicate repair MMR-induced DSB Cr(VI)-treated fibroblasts                                              dependent helicase.  unlike types DSB processed                                              recombination repair RecQ-dependent independent (EXO1) pathways,20&#226;&#8364;&#8220;22                                              reliance WRN-dependent process repair Cr/MMR-induced breaks result                                              persistent DSB. Cr(VI)-treated cells did display relatively slow DSB repair                                              phenomenon particularly noticeable primary human cells showed steady <br />                                              accumulation DSB hours exposure subtoxic environmental doses <br />                                              Cr(VI).24,25 High promoter-repressive activity Rb complexes primary cells results                                              low levels WRN expression,56 limit repair rates Cr-induced DSB                                              tissues. Persistent DSB cause variety gross genetic rearrangements, including <br />                                              chromosomal deletions translocations,57,58 likely contributing high <br />                                              carcinogenicity moderate chromate exposures modern workplace <br />                                              environment.47,59 Consequently, individuals low WRN levels greater risk <br />                                              Cr(VI)-associated genotoxicity carcinogenesis. Cr(VI)-induced DSB                                              predominantly G2 cells repair requires WRN, restrict WRN <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                              availability biological functions rebuilding telomere structures                                              occurs G2 phase.60  potential consequences competition WRN <br />                                              telomeric functions DSB repair slower rates processes  <br />                                              possibly, accelerated attrition telomeres cells individuals chronically exposed                                              Cr(VI). <br />  <br />  <br />                               Abbreviations <br />                                             DSB             double-strand break <br />                                             MMR             mismatch repair <br />                                             PBS             phosphate-buffered saline <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             shRNA           short hairpin RNA <br />                                             PFGE            pulsed-field gel electrophoresis <br />  <br />   <br />                                             Figure 1. Loss WRN decreases survival cells treated Cr(VI) <br />                                             Cell survival determined clonogenic assay. Results means&#194;&#177;SD 2&#226;&#8364;&#8220;3 <br />                                             independent experiments, triplicate dishes dose. seen, error bars <br />                                             smaller symbol. Statistics (Student&#226;&#8364;&#8482;s t-test): *- p&lt;0.05, **- p&lt;0.01 relative                                             WRN-deficient cells.   Clonogenic viability WS NF fibroblasts treated                                             Cr(VI). (B) WRN levels NF  panel) LNS (lower panel) cells expressing targeting <br />                                             nonspecific (GFP) shRNA. (C) Cr(VI) toxicity NF cells expressing WRN-targeting NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             nonspecific (GFP) shRNA. (D) Survival LNS cells expressing WRN GFP-targeting <br />                                             shRNA. <br />  <br />  <br />  <br />  <br />                                                 Cell Cycle. Author manuscript; available PMC 2011 November 30. <br />                             Zecevic et al.                                                                                       Page 13 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Figure 2. Cr(VI) causes dispersion WRN nucleolus <br />                                               Confocal images control 20 &#206;&#188;M Cr(VI)-treated NF cells immunostained                                             WRN nucleolar marker B23. (B) representative confocal image Cr-treated cells <br />                                             displaying colocalization WRN &#206;&#179;-H2AX foci. (C) Presence &#206;&#179;-H2AX foci NF cells <br />                                             different patterns WRN staining. Cells treated 20&#206;&#188;M Cr(VI) fixed                                             immunostaining indicated times. Data means&#194;&#177;SD slides &gt;100 cells <br />                                             scored slide. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 Cell Cycle. Author manuscript; available PMC 2011 November 30. <br />                             Zecevic et al.                                                                                        Page 14 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Figure 3. Persistence Cr-induced DSB WRN-depleted cells <br />                                               Confocal images GFP WRN-shRNA expressing NF cells stained DAPI                                             antibodies 53BP1 &#206;&#179;-H2AX. Shown representative images untreated 10 <br />                                             &#206;&#188;M Cr-treated cells 6 hr post-exposure. (B) Frequency DSB-positive NF cells 6                                             24 hr exposure 10 &#206;&#188;M Cr(VI). Cells &#226;&#8240;&#165;5 foci 53BP1 &#206;&#179;-H2AX NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             counted DSB-positive. WRN -cells expressing WRN-targeting shRNA, GFP - cells <br />                                             expressing nonspecific shRNA. Data means &#194;&#177;SD 5 slides &gt;100 cells analyzed <br />                                             slide. Statistics: *- p&lt;0.05, **- p&lt;0.01 relative shGFP cells. (C) Frequency DSB- <br />                                             positive LNS cells following exposure 30 &#206;&#188;M Cr(VI). Definitions cells panel <br />                                             B. Results means&#194;&#177;SD 3 slides &gt;100 cells counted slide. (D) DSB levels                                             normally cultured NF cells 24 hr post-exposure low Cr(VI) doses. Data means &#194;&#177;SD <br />                                             4 slides &gt;100 cells analyzed slide. (E) Elevated DSB levels NF cells <br />                                             preloaded 0.25 mM ascorbic acid prior Cr(VI) exposure. DSB foci counted                                             24 hr post-Cr. Data means&#194;&#177;SD 4 slides &gt;100 cells counted slide. (F) <br />                                             Determination DSB repair PFGE LNS cells treated 30 &#206;&#188;M Cr(VI) (means <br />                                             &#194;&#177;SD). (G) PFGE chromosomal DNA shGFP- shWRN-LNS cells treated                                             50 30 &#206;&#188;M Cr(VI), respectively. <br />  <br />  <br />  <br />  <br />                                                 Cell Cycle. Author manuscript; available PMC 2011 November 30. <br />                             Zecevic et al.                                                                                            Page 15 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Figure 4. WRN depletion inhibits formation RAD51 foci Cr-treated cells <br />                                               Representative confocal images NF LNS cells stained DAPI anti- <br />                                             RAD51 antibody. Cells treated 10 &#206;&#188;M (NF cells) 30 &#206;&#188;M Cr(VI) (LNS cells)                                             3 hr fixed 6 24 hr later. (B) Induction RAD51 foci Cr(VI) NF cells. Cells NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             3 foci scored focus-positive. Data means&#194;&#177;SD 4 slides &gt;100 <br />                                             cells scored slide. (C) Formation RAD51 foci LNS cells treated 30 &#206;&#188;M <br />                                             Cr(VI). Data means&#194;&#177;SD 4 slides &gt;100 cells counted slide. Statistics                                             panels B C: *-p&lt;0.05, **- p&lt;0.01 relative shGFP cells. (D) Number RAD51 foci- <br />                                             positive WS cells 24 hr post-Cr. Data means&#194;&#177;SD 3 slides 100 cells <br />                                             scored slide. (E) Colocalization WRN RAD51 foci LNS cells 6 24 hr <br />                                             treatment 30 &#206;&#188;M Cr(VI). (F) WRN RAD51 colocalization NF cells 24 hr <br />                                             following exposure 10 &#206;&#188;M Cr(VI). panels E F, nuclei containing clear <br />                                             RAD51 focus colocalizing WRN scored positive. Typical colocalization                                             positive cells 20&#226;&#8364;&#8220;80% RAD51 foci. &#226;&#8364;&#339;&#226;&#710;&#8217;&#226;&#8364;&#65533; Frequency RAD51-positive cells <br />                                             WRN colocalization, &#226;&#8364;&#339;+&#226;&#8364;&#65533; &#226;&#8364;&#8220;frequency cells RAD51 WRN colocalization. <br />                                             Results means&#194;&#177;SD 3 slides &gt;30 RAD51 foci-containing cells scored                                             colocalization. Statistics panels E F: *-p&lt;0.05, **- p&lt;0.01 relative untreated cells. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 Cell Cycle. Author manuscript; available PMC 2011 November 30. <br />                             Zecevic et al.                                                                                          Page 16 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Figure 5. Nucleoplasmic retention WRN Cr(VI)-treated cells requires intact MMR <br />                                               Frequency MLH1&#226;&#710;&#8217;/&#226;&#710;&#8217; MLH1+ HCT116 cells nucleoplasmic WRN following <br />                                             treatment 20 &#206;&#188;M Cr(VI) (means&#194;&#177;SD 3 slides &gt;100 cells analyzed/slide). <br />                                             Statistics: *- p&lt;0.05, **- p&lt;0.01 relative MLH1&#226;&#710;&#8217;/&#226;&#710;&#8217; cells. (B) Western blot protein <br />                                             extracts IMR90 cells expressing nonspecific (Luc), MSH2 MLH1-targeting shRNA. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             (C) Quantitation nuclear WRN dispersion IMR90 cells treated 10 &#206;&#188;M Cr(VI) <br />                                             (means&#194;&#177;SD 3 slides &gt;100 cells analyzed/slide). Statistics: *- p&lt;0.05, **- p&lt;0.01 <br />                                             relative MLH1- MSH2-shRNA. (D) Coimmunoprecipitation WRN MSH6                                             MSH2 control 20 &#206;&#188;M Cr-treated NF cells. (E) Expression MMR proteins GFP- <br />                                             shRNA WRN-shRNA NF cells exposure 20&#206;&#188;M Cr(VI). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 Cell Cycle. Author manuscript; available PMC 2011 November 30. <br />                             Zecevic et al.                                                                                        Page 17 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Figure 6. Rescue WRN hypersensitivity MSH6 depletion <br />                                               Western blot MSH6 WRN NF cells double shRNA infections. WRN- <br />                                             shRNA expressed pSUPER-puro vector, MSH6 &#226;&#8364;&#8220; pSUPER-neo                                             nonspecific GFP-shRNA expressed pSUPER-puro pSUPER-neo <br />                                             depending resistance marker targeting vector. (B) DSB foci (53BP1 + &#206;&#179;-H2AX) <br />                                             WRN-depleted NF cells MSH6 knockdown (&#226;&#8212;&#65533; - WRN-GFP shRNAs, &#226;&#8211;&#161; <br />                                             - GFP-GFP shRNAs, &#226;&#8212;&#8225;- GFP-MSH6 shRNAs, &#226;&#8211;&#178;-WRN-MSH6 shRNAs). Cells                                             treated Cr(VI) 3 hr fixed immunofluorescence 24 hr later. Data means <br />                                             &#194;&#177;SD 3 slides &gt;100 cells counted slide (*- p&lt;0.05 GFP/GFP WRN/ <br />                                             MSH6 relative WRN/GFP cells). (C) Frequency DSB-positive double knockdown NF <br />                                             cells preloaded 0.25 mM ascorbate prior 5 &#206;&#188;M Cr(VI) exposure. Cells fixed NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             DSB foci scoring (53BP1 + &#206;&#179;-H2AX foci) 24 hr post-Cr. Shown means&#194;&#177;SD 3 <br />                                             slides &gt;100 cells counted slide (*- p&lt;0.05, **-p&lt;0.01 relative untreated cells). <br />                                             (D) Frequency RAD51 foci-positive NF cells expressing nonspecific (GFP) MSH6- <br />                                             targeting shRNA following exposure Cr(VI) normal culture conditions. RAD51 <br />                                             foci scored 24 hr post-treatment. Data means&#194;&#177;SD 3 slides &gt;100 cells <br />                                             counted slide. (E) panel D cells preloaded 0.25 mM ascorbate <br />                                             prior treatments Cr(VI). Data means&#194;&#177;SD 3 slides. Statistics panels D                                             E: *- p&lt;0.05, **- p&lt;0.01 relative shGFP cells. <br />  <br />  <br />  <br />  <br />                                                 Cell Cycle. Author manuscript; available PMC 2011 November 30. <br />   <br /> </body></html>